Monday, November 30, 2015

A new study led by Dr. Wendy Maury , Professor of Microbiology, suggests that gamma interferon, which is an FDA-approved drug, may have potential as an antiviral therapy to prevent Ebola infection when given either before or after exposure to the virus. The study, published in the journal PLOS Pathogens,found that gamma interferon, given up to 24 hours after exposure, can inhibit Ebola infection in mice and completely protect the animals from death.

To learn more about this story follow the link: FDA approved drug protects mice from Ebola